Adrienne Farid
Chief Operating Officer presso CENTURY THERAPEUTICS, INC.
Patrimonio netto: 573 646 $ in data 31/03/2024
Profilo
Adrienne Farid is currently the Chief Operations Officer at Century Therapeutics, Inc. She previously worked as a Director at Carisma Therapeutics, Inc., VP-Project Leadership at Celgene Corp., and Global Head-Project & Portfolio Management at Roche Pharmaceuticals, Inc. Farid holds a doctorate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Barnard College.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
03/05/2024 | 137 236 ( 0.17% ) | 573 646 $ | 31/03/2024 |
Posizioni attive di Adrienne Farid
Società | Posizione | Inizio |
---|---|---|
CENTURY THERAPEUTICS, INC. | Chief Operating Officer | 01/04/2021 |
Precedenti posizioni note di Adrienne Farid
Società | Posizione | Fine |
---|---|---|
CELGENE | Corporate Officer/Principal | 01/07/2017 |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01/01/2011 |
CARISMA THERAPEUTICS, INC. | Director/Board Member | - |
Formazione di Adrienne Farid
The Trustees of Columbia University in The City of New York | Doctorate Degree |
Barnard College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
CENTURY THERAPEUTICS, INC. | Health Technology |
CARISMA THERAPEUTICS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
- Borsa valori
- Insiders
- Adrienne Farid